KLRC1 and cancer: In their study they inhibited NKG2A a powerful inhibitory signal in both T and NK cells and the major histocompatibility complex-class I chain related proteins A and B (MICA/B) to avoid shedding on cancer cells and escape from NKG2D recognition by NK cells [138].